EDAP TMS S.A. (EDAP) Earns Buy Rating from HC Wainwright
HC Wainwright reissued their buy rating on shares of EDAP TMS S.A. (NASDAQ:EDAP) in a research report released on Friday. They currently have a $6.50 price objective on the medical equipment provider’s stock.
A number of other equities analysts have also recently weighed in on the company. Zacks Investment Research raised EDAP TMS from a strong sell rating to a hold rating in a report on Thursday, May 18th. ValuEngine raised EDAP TMS from a sell rating to a hold rating in a report on Friday, May 19th.
Shares of EDAP TMS (EDAP) traded up 1.77% during midday trading on Friday, reaching $2.87. The company had a trading volume of 1,000 shares. EDAP TMS has a 12-month low of $2.25 and a 12-month high of $3.85. The company has a 50 day moving average of $2.99 and a 200 day moving average of $2.89. The firm’s market capitalization is $83.22 million.
EDAP TMS (NASDAQ:EDAP) last released its quarterly earnings results on Wednesday, August 23rd. The medical equipment provider reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by $0.03. The business had revenue of $10.40 million during the quarter, compared to analyst estimates of $10 million. EDAP TMS had a positive return on equity of 15.70% and a negative net margin of 0.27%. The business’s revenue for the quarter was up 13.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.10 EPS. Analysts anticipate that EDAP TMS will post $0.18 EPS for the current year.
COPYRIGHT VIOLATION WARNING: “EDAP TMS S.A. (EDAP) Earns Buy Rating from HC Wainwright” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/28/edap-tms-s-a-edap-earns-buy-rating-from-hc-wainwright.html.
Institutional investors have recently added to or reduced their stakes in the company. Archon Capital Management LLC acquired a new position in EDAP TMS during the second quarter worth $2,474,000. Essex Investment Management Co. LLC purchased a new position in shares of EDAP TMS during the second quarter worth approximately $172,000. Virtu KCG Holdings LLC purchased a new position in shares of EDAP TMS during the second quarter worth approximately $117,000. Finally, Hilton Capital Management LLC boosted its position in shares of EDAP TMS by 43.1% in the second quarter. Hilton Capital Management LLC now owns 83,000 shares of the medical equipment provider’s stock worth $274,000 after buying an additional 25,000 shares during the last quarter. 9.49% of the stock is owned by institutional investors.
About EDAP TMS
EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.
Receive News & Stock Ratings for EDAP TMS S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EDAP TMS S.A. and related stocks with our FREE daily email newsletter.